SRZN · Surrozen, Inc./DE
$23.84
-0.13 (-0.52%)
At close · Aug 17
Market Cap
$281.62M
Shares
11.75M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $2,819,017 |
| Charles Williams | Chief Operating Officer and Corporate Secretary | $1,518,919 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $1,520,085 |
| Charles Williams | Chief Financial Officer, Chief Operating Officer and Corporate Secretary | $1,007,326 |
| Yang Li | Executive Vice President, Research | $847,193 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $1,165,250 |
| Wen-Chen Yeh | M.D., Ph.D. Former Chief Scientific Officer | $716,294 |
| Charles Williams | Chief Financial Officer, Chief Operating Officer and Corporate Secretary | $675,526 |
| Yang Li | Executive Vice President, Research | $576,732 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $1,895,450 |
| Charles Williams | Chief Financial Officer, Chief Operating Officer and Corporate Secretary | $904,215 |
| Wen-Chen Yeh | M.D., Ph.D. Former Chief Scientific Officer | $867,493 |
| Yang Li | Executive Vice President, Research | $662,960 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Craig Parker | President and Chief Executive Officer | $4,212,626 |
| Wen-Chen Yeh | M.D., Ph.D. Chief Scientific Officer | $744,073 |
| Charles Williams | Chief Financial Officer | $635,236 |
| Gad Soffer | Former Chief Executive Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Charles Williams | Chief Financial Officer | $581,293 |
| Craig Parker | President and Chief Executive Officer | $553,500 |
| Wen-Chen Yeh | M.D., Ph.D. Chief Scientific Officer | $497,560 |
| Gad Soffer | Former Chief Executive Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Shao-Lee Lin, M.D., Ph.D. | Board of Directors | Resigned | 2026-01-30 |
| Andrew Maleki | Chief Financial Officer | Appointed | 2025-11-07 |
| Tim Kutzkey, Ph.D. | member of our board of directors | Resigned | 2024-07-01 |
| Charles Williams | Chief Operating Officer | Appointed | 2024-02-07 |
| Wen-Chen Yeh, M.D., Ph.D. | Scientific Advisory Board | Appointed | 2023-07-19 |
| Eric Bjerkholt | Class I director | Appointed | 2023-04-05 |
Key facts
CIK
1824893
CUSIP
86889P208
13F (30d)
80 filings
77 filers
Visit website
Investor relations